| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
38,852 |
33,948 |
$1.86M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,106 |
27,259 |
$1.50M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,821 |
13,290 |
$1.00M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,602 |
953 |
$944K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,497 |
10,082 |
$774K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,941 |
3,657 |
$723K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,180 |
3,104 |
$700K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,966 |
6,646 |
$592K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,470 |
10,132 |
$541K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,441 |
1,607 |
$522K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,440 |
3,171 |
$507K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,178 |
7,852 |
$471K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,438 |
2,303 |
$468K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,522 |
5,377 |
$467K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,174 |
2,097 |
$441K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,798 |
3,712 |
$432K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,100 |
4,091 |
$410K |
| 0360 |
|
3,558 |
3,176 |
$389K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,732 |
14,433 |
$354K |
| 80053 |
Comprehensive metabolic panel |
33,554 |
27,728 |
$351K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,704 |
4,103 |
$320K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,817 |
6,252 |
$294K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,351 |
8,552 |
$283K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,570 |
909 |
$276K |
| A4649 |
Surgical supply; miscellaneous |
30,719 |
13,454 |
$269K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,565 |
4,197 |
$267K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,109 |
3,043 |
$225K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,780 |
2,622 |
$220K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
35,530 |
29,486 |
$210K |
| J3490 |
Unclassified drugs |
9,616 |
4,775 |
$185K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,031 |
8,520 |
$179K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
763 |
751 |
$151K |
| 71045 |
Radiologic examination, chest; single view |
12,805 |
12,057 |
$147K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,151 |
1,133 |
$144K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,481 |
4,281 |
$140K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,817 |
2,731 |
$137K |
| 0160 |
|
1,582 |
818 |
$136K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,197 |
2,135 |
$119K |
| 93971 |
|
1,394 |
1,357 |
$111K |
| 83880 |
|
5,593 |
5,141 |
$107K |
| 84484 |
|
12,917 |
10,829 |
$96K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,836 |
2,828 |
$82K |
| 83690 |
|
13,422 |
12,157 |
$79K |
| 76830 |
Ultrasound, transvaginal |
1,448 |
1,404 |
$75K |
| 81001 |
|
21,796 |
20,109 |
$71K |
| 71046 |
Radiologic examination, chest; 2 views |
3,441 |
3,376 |
$68K |
| 77066 |
Tomosynthesis, mammo |
699 |
696 |
$68K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,701 |
1,674 |
$64K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,568 |
8,066 |
$64K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,330 |
2,900 |
$63K |
| 87040 |
|
7,433 |
4,354 |
$63K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,688 |
2,637 |
$62K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
6,785 |
5,432 |
$58K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,939 |
7,720 |
$58K |
| 93970 |
|
397 |
389 |
$56K |
| 76801 |
|
836 |
729 |
$53K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,194 |
4,077 |
$51K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,320 |
2,050 |
$50K |
| Z7502 |
|
1,320 |
1,279 |
$49K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,414 |
4,074 |
$48K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,042 |
1,021 |
$43K |
| J2704 |
Injection, propofol, 10 mg |
2,784 |
2,710 |
$42K |
| 83605 |
|
5,389 |
4,608 |
$42K |
| 99070 |
|
610 |
356 |
$41K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,380 |
1,361 |
$39K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,429 |
4,938 |
$37K |
| 76642 |
|
739 |
736 |
$37K |
| 77065 |
Tomosynthesis, mammo |
436 |
430 |
$35K |
| 80143 |
|
1,460 |
1,339 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,698 |
4,603 |
$33K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
652 |
611 |
$31K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
429 |
423 |
$30K |
| 72100 |
|
1,094 |
1,082 |
$28K |
| 80179 |
|
1,445 |
1,333 |
$27K |
| 73630 |
|
1,209 |
1,183 |
$27K |
| 73562 |
|
1,247 |
1,221 |
$25K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,681 |
1,997 |
$25K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
505 |
500 |
$24K |
| 87081 |
|
4,338 |
4,259 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
740 |
721 |
$23K |
| 73610 |
|
973 |
951 |
$22K |
| 73030 |
|
867 |
841 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,518 |
2,399 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
595 |
580 |
$19K |
| 83735 |
|
5,599 |
4,013 |
$18K |
| 81025 |
|
4,513 |
4,362 |
$18K |
| 84703 |
|
3,377 |
3,139 |
$17K |
| 74018 |
|
851 |
829 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,354 |
2,258 |
$17K |
| 85379 |
|
2,093 |
2,045 |
$16K |
| 87186 |
|
2,315 |
2,233 |
$16K |
| 90715 |
|
479 |
478 |
$16K |
| 73130 |
|
786 |
759 |
$16K |
| 85610 |
|
5,808 |
5,447 |
$16K |
| 88342 |
|
1,414 |
1,398 |
$16K |
| 87400 |
|
1,975 |
1,773 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,668 |
1,627 |
$16K |
| J2060 |
Injection, lorazepam, 2 mg |
2,722 |
2,312 |
$14K |
| 82550 |
|
2,964 |
2,817 |
$14K |
| 87077 |
|
1,974 |
1,872 |
$14K |
| 99199 |
Unlisted special service, procedure or report |
291 |
265 |
$13K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
56 |
55 |
$13K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
675 |
522 |
$13K |
| 0250 |
|
2,832 |
1,612 |
$12K |
| 84145 |
|
466 |
446 |
$11K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
77 |
76 |
$10K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
479 |
476 |
$10K |
| 73110 |
|
431 |
416 |
$10K |
| 82962 |
|
1,685 |
1,065 |
$9K |
| 85730 |
|
2,389 |
2,310 |
$9K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
96 |
55 |
$8K |
| 88313 |
|
932 |
925 |
$8K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,581 |
1,381 |
$8K |
| 86140 |
|
1,444 |
1,392 |
$7K |
| 84702 |
|
645 |
549 |
$7K |
| 29125 |
|
409 |
399 |
$7K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,479 |
1,333 |
$7K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
365 |
354 |
$6K |
| 87807 |
|
926 |
902 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,024 |
953 |
$6K |
| 85027 |
|
1,238 |
1,149 |
$6K |
| 87088 |
|
1,034 |
1,010 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
309 |
302 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
39 |
39 |
$5K |
| 86901 |
|
1,310 |
1,227 |
$5K |
| 0710 |
|
262 |
261 |
$5K |
| 82948 |
|
2,204 |
1,543 |
$5K |
| 70496 |
|
26 |
25 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
180 |
161 |
$5K |
| 70486 |
|
52 |
52 |
$5K |
| 76641 |
|
51 |
51 |
$5K |
| 70498 |
|
26 |
25 |
$5K |
| 77080 |
|
150 |
150 |
$4K |
| 93041 |
|
245 |
237 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
453 |
417 |
$4K |
| 0259 |
|
931 |
524 |
$4K |
| 71250 |
|
43 |
42 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
43 |
37 |
$3K |
| 84100 |
|
2,635 |
1,546 |
$3K |
| 85007 |
|
1,171 |
1,084 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36 |
31 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
80 |
69 |
$3K |
| 72131 |
|
25 |
25 |
$2K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
15 |
15 |
$2K |
| 0270 |
|
1,566 |
1,028 |
$2K |
| 85652 |
|
840 |
817 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
312 |
294 |
$2K |
| 12001 |
|
77 |
77 |
$2K |
| 80061 |
Lipid panel |
655 |
632 |
$2K |
| 86900 |
|
631 |
603 |
$1K |
| 76770 |
|
41 |
41 |
$1K |
| 72040 |
|
83 |
83 |
$1K |
| 93017 |
|
29 |
29 |
$1K |
| 29515 |
|
110 |
105 |
$1K |
| G0378 |
Hospital observation service, per hour |
29 |
27 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
345 |
329 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
190 |
168 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
343 |
191 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
27 |
27 |
$1K |
| 87070 |
|
196 |
189 |
$1K |
| 94060 |
|
41 |
41 |
$1K |
| 73140 |
|
94 |
91 |
$999.81 |
| 76775 |
|
38 |
37 |
$984.13 |
| 36415 |
Collection of venous blood by venipuncture |
810 |
459 |
$766.52 |
| 73080 |
|
40 |
39 |
$717.31 |
| 83874 |
|
137 |
127 |
$711.23 |
| Z7610 |
|
64 |
42 |
$679.08 |
| 86769 |
|
25 |
21 |
$674.08 |
| 94729 |
|
12 |
12 |
$497.40 |
| 82150 |
|
136 |
131 |
$487.95 |
| 94726 |
|
12 |
12 |
$455.88 |
| 80076 |
|
59 |
59 |
$364.51 |
| 12011 |
|
14 |
14 |
$339.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
60 |
57 |
$329.34 |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
27 |
27 |
$300.00 |
| 0636 |
|
70 |
70 |
$280.95 |
| 73502 |
|
12 |
12 |
$265.07 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
76 |
74 |
$206.91 |
| 86308 |
|
41 |
41 |
$194.85 |
| 94664 |
|
14 |
14 |
$179.60 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
384 |
371 |
$152.76 |
| 87205 |
|
75 |
69 |
$141.27 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
28 |
27 |
$137.08 |
| 81003 |
|
93 |
92 |
$134.04 |
| 86850 |
|
67 |
67 |
$132.43 |
| 94760 |
|
15 |
15 |
$72.67 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15 |
12 |
$69.42 |
| 84439 |
|
13 |
12 |
$44.31 |
| J1644 |
Injection, heparin sodium, per 1000 units |
13 |
12 |
$41.76 |
| 87641 |
|
14 |
13 |
$0.00 |